Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Boehringer Ingelheim
Argus Health
Chubb
US Army
McKesson
Mallinckrodt
Cerilliant
Cipla

Generated: October 23, 2017

DrugPatentWatch Database Preview

OXALIPLATIN Drug Profile

« Back to Dashboard

Which patents cover Oxaliplatin, and what generic Oxaliplatin alternatives are available?

Oxaliplatin is a drug marketed by Actavis Totowa, Fresenius Kabi Oncol, Sandoz Inc, Hospira Worldwide, Hospira Inc, Qilu Pharm Co Ltd, Sandoz, Sun Pharma Global, Fresenius Kabi Usa, Cipla Ltd, Gland Pharma Ltd, Sanja Pharms Co, Mylan Labs Ltd, Teva Pharms, Jiangsu Hengrui Med, Accord Hlthcare, and Luitpold Pharms Inc. and is included in twenty-four NDAs.

The generic ingredient in OXALIPLATIN is oxaliplatin. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the oxaliplatin profile page.

Summary for Tradename: OXALIPLATIN

US Patents:0
Applicants:17
NDAs:24
Suppliers / Packagers: see list19
Clinical Trials: see list1,271
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXALIPLATIN at DailyMed

Pharmacology for Tradename: OXALIPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hengrui Med
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)203869-001Jun 18, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)090849-001Apr 28, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)200979-002Aug 8, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)207474-003Mar 21, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)207385-001May 23, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Sanja Pharms Co
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)205529-002Sep 6, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)090849-002Apr 28, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)090030-001Jan 31, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Totowa
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)078803-001Aug 8, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)078818-002Aug 7, 2009APRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Novartis
Dow
Merck
Accenture
Julphar
Citi
QuintilesIMS
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot